Binding of iralukast to serum proteins and erythrocytes: Measurements using ultrafiltration and an erythrocyte partitioning method

European Journal of Pharmaceutical Sciences

Volumn 7, Issue 2, 1999, Pages 167-173

  Colussi, Danielle ^a   Parisot, Carole ^a   Lefèvre, Gilbert ^a  

^a NOVARTIS PHARMA K K   (Japan)

Author keywords

Distribution; Erythrocyte partitioning method; Iralukast; Protein binding; Ultrafiltration

Indexed keywords

ALBUMIN; CARBON 14; IMMUNOGLOBULIN; IRALUKAST; OROSOMUCOID; PLASMA PROTEIN;

ADSORPTION; ANIMAL TISSUE; ARTICLE; BABOON; CONTROLLED STUDY; DOG; DRUG PROTEIN BINDING; ERYTHROCYTE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; ISOTOPE LABELING; MONKEY; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; RABBIT; ULTRAFILTRATION;

BENZOPYRANS; BLOOD PROTEINS; ERYTHROCYTES; HUMANS; LEUKOTRIENE ANTAGONISTS; PROTEIN BINDING; ULTRAFILTRATION;

EID: 0032932742     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0987(98)00025-6     Document Type: Article

References (7)

1. Galemmo R., Gavai A., Huang F. Recent developments in sulphidopeptide leukotriene recept antogonists. Curr. Opin. Ther. Patents. 2(6):1992;811-833.
2. Maulard C., Urien S., Bastian G., Tillement J.P. Binding of retelliptine, a new antitumoral agent, to serum proteins and erythrocytes. Biochem. Pharmacol. 40(4):1990;895-898.
3. Morin D., Zini R., Ledewyn S., Colonna J., Czajka M., Tillement J.P. Binedaline binding to plasma proteins and red blood cells in humans. J. Pharm. Sci. 74(7):1985;727-730.
4. Muret P., Makki S., Urien S., Agache P., Bechtel P., Tillement J.P. Binding of 5-methoxypsoralen to blood fractions. Skin Pharmacol. 6:1993;45-51.
5. Roos A., Hinderling P. Protein binding and erythrocyte partitioning of the antirheumatic proquazone. J. Pharm. Sci. 70(3):1981;252-257.
6. Urien S., Claudepierre P., Meyer J., Brandt R., Tillement J.P. Comparative binding of etretinate and acitretin to plasma proteins and erythrocytes. Biochem. Pharmacol. 44(9):1992;1891-1893.
7. Urien S., Nguyen P., Bastian G., Lucas C., Tillement J.P. Binding of a new multidrug resistance modulator, S9788, to human plasma proteins and erythrocytes. Invest. New Drugs. 13:1995;37-41.